The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene
- 11 November 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (45) , 17420-17425
- https://doi.org/10.1073/pnas.0710725105
Abstract
Parafibromin is a tumor suppressor protein encoded by HRPT2, a gene recently implicated in the hereditary hyperparathyroidism–jaw tumor syndrome, parathyroid cancer, and a subset of kindreds with familial isolated hyperparathyroidism. Human parafibromin binds to RNA polymerase II as part of a PAF1 transcriptional regulatory complex. The physiologic targets of parafibromin and the mechanism by which its loss of function can lead to neoplastic transformation are poorly understood. We show here that RNA interference with the expression of parafibromin or Paf1 stimulates cell proliferation and increases levels of the c-myc proto-oncogene product, a DNA-binding protein and established regulator of cell growth. This effect results from both c-myc protein stabilization and activation of the c-myc promoter, without alleviation of the c-myc transcriptional pause. Chromatin immunoprecipitation demonstrates the occupancy of the c-myc promoter by parafibromin and other PAF1 complex subunits in native cells. Knockdown of c-myc blocks the proliferative effect of RNA interference with parafibromin or Paf1 expression. These experiments provide a previously uncharacterized mechanism for the anti-proliferative action of the parafibromin tumor suppressor protein resulting from PAF1 complex-mediated inhibition of the c-myc proto-oncogene.Keywords
This publication has 30 references indexed in Scilit:
- Ras mediates cell survival by regulating tuberinOncogene, 2007
- Parafibromin inhibits cancer cell growth and causes G1 phase arrestBiochemical and Biophysical Research Communications, 2006
- Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism–jaw tumour syndromeClinical Endocrinology, 2006
- Histone H2B Monoubiquitination Functions Cooperatively with FACT to Regulate Elongation by RNA Polymerase IICell, 2006
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle ArrestMolecular and Cellular Biology, 2005
- The human PAF complex coordinates transcription with events downstream of RNA synthesisGenes & Development, 2005
- Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expressionOncogene, 2004
- HRPT2 mutations are associated with malignancy in sporadic parathyroid tumoursJournal of Medical Genetics, 2003
- HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndromeNature Genetics, 2002